Stockscreener 앱 받기
248.25
0.24%
0.595
전일 마감가:
$247.66
열려 있는:
$247.63
하루 거래량:
309.77K
Relative Volume:
0.42
시가총액:
$19.22B
수익:
$12.71B
순이익/손실:
$435.50M
주가수익비율:
48.20
EPS:
5.15
순현금흐름:
$843.20M
1주 성능:
+8.13%
1개월 성능:
+10.34%
6개월 성능:
+8.36%
1년 성능:
+23.32%
1일 변동 폭
$245.95
$249.32
1주일 범위
$218.76
$249.32
52주 변동 폭
$191.97
$258.59
래버러토리 코퍼레이션 Stock (LH) Company Profile
명칭
Labcorp Holdings Inc
전화
(336) 229-1127
주소
358 S MAIN ST, BURLINGTON, NC
LH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
248.26 | 19.22B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
423.03 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
198.92 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
480.58 | 35.17B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
109.11 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.85 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
래버러토리 코퍼레이션 Stock (LH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-02 | 개시 | Redburn Atlantic | Buy |
| 2025-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-01-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-30 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-10-01 | 개시 | Piper Sandler | Neutral |
| 2024-03-25 | 업그레이드 | Argus | Hold → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-02-09 | 개시 | Evercore ISI | In-line |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-19 | 다운그레이드 | Argus | Buy → Hold |
| 2022-08-22 | 재개 | Morgan Stanley | Overweight |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-01-11 | 업그레이드 | Argus | Hold → Buy |
| 2021-01-11 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-13 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 재개 | Deutsche Bank | Buy |
| 2020-05-15 | 업그레이드 | Mizuho | Neutral → Buy |
| 2020-04-29 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2019-07-16 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-01-17 | 개시 | UBS | Buy |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-30 | 다운그레이드 | Argus | Buy → Hold |
| 2018-10-25 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | 재개 | BofA/Merrill | Buy |
| 2018-06-07 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | 개시 | Argus | Buy |
모두보기
래버러토리 코퍼레이션 주식(LH)의 최신 뉴스
Labcorp Holdings Inc, BioReference Health, OPKO Health, Inc. - Olean Times Herald
Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight - GuruFocus
Labcorp: Q1 Earnings Snapshot - Bluefield Daily Telegraph
Why Labcorp (LH) is a Top Value Stock for the Long-Term - Yahoo Finance
BlackRock, Inc. Reduces Stake in Labcorp Holdings Inc. - GuruFocus
Baird Adjusts Labcorp Holdings' Price Target to $267 From $253 - marketscreener.com
Labcorp (LH) Price Target Raised by Baird Following Q1 Results | - GuruFocus
Labcorp’s Stock Price Target Raised on Strong Q1 (NYSE: LH) - AskTraders.com
Labcorp Holdings First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Barclays Adjusts Labcorp (LH) Price Target, Maintains Equal Weig - GuruFocus
Barclays Adjusts Labcorp (LH) Price Target, Maintains Equal Weight Rating | LH Stock News - GuruFocus
Labcorp targets 10% EPS growth with new diagnostics and acquisitions strategy - MSN
Labcorp Q1 2025 slides: Revenue up 5.3%, maintains strong 2025 outlook - Investing.com
Labcorp beats earnings estimates, stock jumps 5% as acquisitions drive growth - The Business Journals
Labcorp Q1 2025 slides: Revenue up 5.3%, maintains strong 2025 outlook By Investing.com - Investing.com Canada
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Our Labcorp Price Target as Latest Results Surprise - TheStreet Pro
Labcorp Outpaces Expectations With Strong Diagnostic Demand - Finimize
Labcorp (LH) Q1 Earnings Miss Estimates, Revenue Guidance Reaffi - GuruFocus
Labcorp (LH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Labcorp (LH) Revises 2025 Revenue Outlook with Strong Growth Pro - GuruFocus
Labcorp Q1 Earnings Surpass Estimates, Revenues Miss, Stock Gains - Yahoo Finance
Labcorp Holdings Inc Reports Q1 2025 Earnings: EPS of $2.52 and Revenue of $3.35 Billion, Both Below Estimates - GuruFocus
Labcorp (LH) Beats Q1 Earnings Estimates - Yahoo Finance
Labcorp (LH) Reports First Quarter 2025 Financial Results | LH S - GuruFocus
Labcorp Announces 2025 First Quarter Results - The Malaysian Reserve
Labcorp Misses Revenue Expectations but Reports EPS Growth in Q1 2025News and Statistics - IndexBox
Labcorp beats quarterly profit estimate on diagnostic test demand - Reuters
Labcorp Holdings Inc. Q1 Profit Decreases, But Beats Estimates - Nasdaq
Labcorp (NYSE:LH) Reports Sales Below Analyst Estimates In Q1 Earnings - Yahoo Finance
Labcorp Announces 2025 First Quarter Results and Updates Full-Year Guidance - TradingView
Earnings Flash (LH) Labcorp Holdings Posts Q1 Revenue $3.35B, vs. FactSet Est of $3.40B - marketscreener.com
Labcorp to Announce First Quarter Financial Results on April 29, 2025 - GuruFocus
Earnings Preview: Laboratory Corp - Benzinga
Labcorp Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72 - simplywall.st
Labcorp (LH) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo
Labcorp Holdings (NYSE:LH) Expands Precision Oncology Portfolio with FDA-Authorized Liquid Biopsy Tests - Yahoo Finance
Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72 - Yahoo Finance
HUMEarnings Scorecard: LabCorpAnalyst Blog - ADVFN
Labcorp Launches Molecular Residual Disease And Liquid Biopsy Solutions - marketscreener.com
Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions – Company Announcement - Financial Times
Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions - Seeking Alpha
Labcorp (LH) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
The three-year earnings decline is not helping Labcorp Holdings' (NYSE:LH share price, as stock falls another 6.9% in past week - Yahoo Finance
Labcorp acquires ambulatory outreach laboratory business of NMHS - Yahoo Finance
InStride’s Hybrid Clinical Cohorts Fill High-Need Roles in Healthcare - GlobeNewswire Inc.
Drug Abuse Testing Market Forecast Report and Company Analysis 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad Labs, Medtronic - Yahoo Finance
Labcorp Holdings: Regaining Credibility - Seeking Alpha
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Labcorp Q1 Earnings Preview: Diagnostics Arm Likely to Drive Growth - MSN
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. - marketscreener.com
래버러토리 코퍼레이션 (LH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.31%
자본화:
|
볼륨(24시간):